Copyright
©The Author(s) 2020.
World J Gastroenterol. May 7, 2020; 26(17): 2064-2081
Published online May 7, 2020. doi: 10.3748/wjg.v26.i17.2064
Published online May 7, 2020. doi: 10.3748/wjg.v26.i17.2064
Figure 10 Potential pathways that epigallocatechin gallate may affect.
A: Heatmap of dysregulated genes in colorectal cancer expression profile from The Cancer Genome Atlas; B: Twenty-eight collective genes that were dysregulated among the 78 collective targets of epigallocatechin gallate and colorectal cancer; C: Pathways that the 28 genes were enriched by Kyoto Encyclopedia of Genes and Genomes analysis; D: Biological process that 28 genes were enriched by Gene ontology analysis. CRC: Colorectal cancer; EGCG: Epigallocatechin gallate.
- Citation: Wang Y, Jin HY, Fang MZ, Wang XF, Chen H, Huang SL, Kong DS, Li M, Zhang X, Sun Y, Wang SM. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats. World J Gastroenterol 2020; 26(17): 2064-2081
- URL: https://www.wjgnet.com/1007-9327/full/v26/i17/2064.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i17.2064